Diabetic nephropathy is a condition characterized by persistent albuminuria, an increase in arterial blood pressure, a relentless decline in renal function and increased cardiovascular morbidity and mortality. It occurs in 10±40 % of patients with Type I (insulin-dependent) diabetes mellitus [1±3]. Although a strict glycaemic control diminishes the risk of diabetic microvascular complications [4] , the development of diabetic nephropathy cannot be explained by poor glycaemic control alone [5] . Diabetic nephropathy has been found to cluster in families [6±8] to an extent that cannot be explained by shared environmental factors alone [9] . In addition, the majority of family studies have reported an excess of hypertension [10±13] and cardiovascular disease [14, 15] in parents of Type I diabetic patients with nephropathy. There- Diabetologia (1999) 
fore, substantial evidence suggests a role for genetic factors in the development of diabetic nephropathy.
Type II (non-insulin-dependent) diabetes is considered to be a heterogenous disease resulting from defects in both insulin secretion and insulin action [16] . Although the exact pathogenetic mechanisms are poorly understood, the disease seems to be influenced by genetic factors since the concordance rate in identical twins is high [17] , as is the life-time risk of Type II diabetes in the offspring of Type II diabetic patients [18] . Type I diabetes, on the other hand, has been thought to be a more homogenous disease characterized by acute insulin deficiency due to autoimmune destruction of pancreatic beta cells. It could be hypothesized, however, that a certain degree of heterogeneity exists also in Type I diabetes. In this respect, Type I diabetic patients with a family history of Type II diabetes could represent a distinct subphenotype, especially since Type II diabetes is more prevalent among relatives of Type I diabetic patients compared with relatives of non-diabetic subjects [19] . So far, little is known about the impact of a family history of Type II diabetes in patients with Type I diabetes.
In non-diabetic subjects with a family history of Type II diabetes, a spectrum of metabolic disturbances, such as insulin resistance, abdominal obesity, increased blood pressure and lipid abnormalities, has been described [20, 21] . Similar metabolic and haemodynamic disturbances have also been found in the early stages of diabetic nephropathy in Type I diabetes [22±26] . Furthermore, in Pima Indians, a link between familial Type II diabetes and diabetic nephropathy has been reported, since diabetic nephropathy in parents, compared with parental diabetes alone, is associated with an increased risk of diabetes in the offspring [27] . We hypothesized that a link between familial Type II diabetes and nephropathy exists also in Type I diabetes and, therefore, our aim was to examine the association between a family history of Type II diabetes and diabetic nephropathy in patients with Type I diabetes.
Subjects and methods
Subjects. After approval from the local ethics committee, 158 Type I diabetic patients with diabetic nephropathy were invited to participate in the study. The patients constituted a random sample of all Type I diabetic patients with diabetic nephropathy attending the renal outpatient clinic or the dialysis unit of Helsinki University Central Hospital between November 1995 and December 1997. Twenty-one patients were unwilling or unable to participate and, consequently, 137 Type I diabetic patients with diabetic nephropathy were included in the study. Thirty-four Type I diabetic patients with normal albumin excretion rate attending the diabetic outpatient clinic of the same hospital from September 1990 to February 1992 [24] were recruited consecutively. The control group was further increased by an advertisement in the newspaper of the Helsinki Diabetes Association. All Type I diabetic patients (n = 20) that responded to the advertisement and who fulfilled the inclusion criteria were included. Informed consent was obtained from all participating patients.
The clinical characteristics of the Type I diabetic patients are listed in Table 1 . All patients had an onset of diabetes before the age of 30 years, had insulin treatment initiated within a year after diagnosis and had been uninterruptedly treated with insulin alone since then. At the time of the study all of them received multiple daily injections of insulin. All patients with diabetic nephropathy had present or past documentation of persistent macroalbuminuria [urinary albumin excretion rate (U-AER) exceeding 200 mg/min in at least two of three consecutive timed overnight urine collections] in the absence of any clinical or laboratory evidence of other kidney or renal tract disease. At the time of the study, 43 % of the patients with diabetic nephropathy had progressed to end stage renal disease (ESRD). All patients in the control group had a duration of diabetes exceeding 15 years and a U-AER less than 20 mg/min in three overnight urine samples. None of the patients in the control group had a history of micro-or macroalbuminuria. The participating patients were interviewed using a standardized questionnaire regarding parents being alive or dead, age of the parents at the time of the study and parental diabetes or antihypertensive treatment. If a parent was dead, cause of death and age at death were asked for.
Assessment of family history of diabetes, hypertension and cardiovascular death. Information on vital status, diabetes, antihypertensive treatment and cardiovascular death was available in 377 (99 %), 377 (99 %), 369 (97 %) and 374 (98 %), respectively, of the the participating patients' parents. To confirm the cases of parental diabetes and to test the reliability of patientreported data on parental hypertension and cardiovascular death, information was obtained by interviewing living parents and by reviewing medical records and death certificates of dead parents. Confirmation of data was carried out in all parents classified as diabetic by their Type I diabetic offspring (n = 66; 50 of the patients with and 16 of the patients without nephropathy) and, furthermore, in a sample of 221 of all 311 (217 parents of patients with and 94 parents of patients without nephropathy) presumed non-diabetic parents. The sample of 221 presumed non-diabetic parents (138 of patients with and 83 of patients without nephropathy) was selected as follows: firstly, a medical history was obtained from the living parents in relation to the OGTT after data was collected from the patients (n = 95 and 55; see Assessment of glucose tolerance in previously non-diabetic parents). Secondly, to test the reliability of data on the presumed non-diabetic parents that did not attend the outpatient clinic, the validation procedure was further carried out in a subgroup of 71 parents (n = 43 and 28) of whom 18 were alive (n = 14 and 4) and 53 were dead (n = 29 and 24). A diagnosis of diabetes could not be confirmed in 16 parents while evidence of diabetes was found in none of the parents classified as non-diabetic by their Type I diabetic offspring. Thus, the diabetic patients identified parental diabetes with a specificity of 93 % and a sensitivity of 100 %. The reliability of patient-reported data was similar in patients with and without nephropathy (specificity 93 %, sensitivity 100 % in both groups) and was not substantially affected by parents being alive or dead (living parents: specificity 95 %, sensitivity 100 %, dead parents; specificity 88 %, sensitivity 100 %). Only confirmed cases of parental diabetes were included in the analysis. Diabetes was classified as Type I diabetes, if age at onset was less than or equal to 40 years and the parent had received treatment with insulin alone since diagnosis. All other cases of confirmed parental diabetes were classified as Type II diabetes.
The sensitivity of proband-reported parental hypertension was found to be 89 %, while the specificity was 90 %. Parental cardiovascular death was considered present, if the proband reported death from cardiac causes, stroke or rupture of an aortic aneurysm. In the subgroup of 76 (51 %) of the 149 dead parents for whom death certificates were obtained, data given by the patients identified cardiovascular disease as immediate or underlying cause of death in their parents with a sensitivity and specificity of 83 % and 97 %, respectively.
Assessment of glucose tolerance in previously non-diabetic parents. At the time of the study, 138 parents of patients with nephropathy and 69 parents of patients without nephropathy were alive and had no history of diabetes. Those who lived within a reasonable distance from the research facilities in Helsinki and who were not suffering from any major disabling condition were invited to take part in an OGTT. The OGTT was therefore done in 95 (69 %) and 55 (76 %; p = NS) living, nondiabetic parents of patients with and without nephropathy.
The parents who had an OGTT were studied in the morning after an overnight fast. All participating parents gave their informed consent. A careful medical history regarding diabetes, cardiovascular disease, hypertension, smoking habits and regular medication was taken from all participating parents using a standardized questionnaire. Plasma glucose was measured in duplicates in the fasting state and at 30, 60 and 120 min after ingestion of 75 g glucose in 200 ml of water. Diabetes and impaired glucose tolerance (IGT) in the OGTT were defined according to the 1985 WHO criteria [28] . Abnormal glucose tolerance was defined as IGT and diabetes combined. Incremental area under the glucose curve was calculated by the trapezoidal rule.
Body weight (to the closest 0.1 kg) and height (to the closest cm) were measured in indoor clothing. BMI was calculated as weight (kg)/[height (m)] 2 . Waist circumference was measured midway between the iliac crest and the lowest rib and hip circumference at the widest part of the gluteal region. Waist-hip ratio (WHR) was calculated as waist (cm)/hip (cm). Smoking was defined as present smoking of at least one daily cigarette, cigar or pipe during 1 year before the examination. Blood pressure was measured auscultatory with a calibrated mercury sphygmomanometer from the righthand arm with the subject in sitting position after a 5 min rest. Systolic (Korotkoff I) and diastolic (Korotkoff V) blood pressure was measured twice and the mean value was used in analyses.
Laboratory tests. Plasma glucose was measured with a glucose oxidase method using a Beckman Glucose Analyser II (Beckman, Fullerton, Calif., USA) with a within assay coefficient of variation of 1.0 %. Urinary albumin concentration was determined by radioimmunoassay (Albumin-RIA, Pharmacia, Uppsala, Sweden) with a within assay coefficient of variation of 4.1 %. Glycated haemoglobin was measured by high pressure liquid chromatography (normal range: 4.0±6.0 %) and serum creatinine by a kinetic Jaffe' method (normal range: women 50±110, men 55±115 mmol/l). 
The significance of difference in continuous variables was tested using the Student's t test (normally distributed) and with the Mann-Whitney U test (non-normally distributed). Overall and cardiovascular parental death rate was calculated with a Kaplan-Meier analysis using a SPSS 7.5.1 statistical package (SPSS, Chicago, USA), which takes into account the variability in length of follow-up. In the analysis, parents contributed person-years to follow-up until death or, whether alive, until the age at the time of the study. When overall death rate was assessed, life or death status was used as the censoring indicator, while death from cardiovascular disease was used as censoring indicator in the cardiovascular death rate analysis. The significance of the difference in survival between the two groups was determined using the logrank test. To evaluate the independent association between familial factors and diabetic nephropathy, a multiple forward stepwise logistic regression analysis was done including potential confounding factors and the adjusted odds ratios and the 95 % confidence interval calculated (SPSS 7.5.1). A two-tailed p-value less than 0.05 was considered statistically significant.
Results
Parental overall and cardiovascular mortality. Of the 271 parents of patients with nephropathy and 106 parents of patients without nephropathy where data on life or death status was available, 107 (39 %) and 34 (32 %) were dead (difference: 7 % (95 % CI: ±3 to 18 %, p = NS). A Kaplan-Meier survival analysis showed a higher overall death rate among parents of patients with nephropathy compared with parents of patients without (log rank test: p = 0.039). An additional survival analysis was done dealing exclusively with parental death from cardiovascular cause. No significant difference was found in the cardiovascular death rate between the parents in the two groups although there was a tendency towards higher cardiovascular death rate among mothers of patients with nephropathy compared with mothers of patients without nephropathy (p = 0.095) in a sex-stratified analysis.
Parental history of diabetes and hypertension. Sixtysix parents (54 of patients with and 12 of patients without nephropathy, p = 0.048) were reported to have diabetes by their Type I diabetic offspring. A diagnosis of diabetes could not be confirmed in 16 parents (ten of patients with, six of patients without nephropathy). As shown in Table 2 , confirmed diabetes was more prevalent among parents of patients with nephropathy. After classification of confirmed cases of diabetes into Type I and Type II diabetes, there was an excess of Type II diabetes among parents of patients with nephropathy. The median age at onset of Type II diabetes was 60 years (range: 40±89) in parents of patients with nephropathy and 66 years (56±85) in parents of patients without nephropathy (p = NS). In addition, there was an excess of hypertension in parents of patients with nephropathy.
In a patient-based analysis, 34 (25 %) of the patients with nephropathy compared with five (9 %) of patients without nephropathy had a confirmed diagnosis of Type II diabetes in one or both parents [difference 16 % (95 % CI: 5 to 26 %), p = 0.019]. Corresponding proportions of patients with and without nephropathy with antihypertensive treatment in one or both parents were 56 % (n = 75) and 36 % (n = 19); difference 20 % (95 % CI: 4 to 35 %), p = 0.015. Parental history of Type II diabetes and hypertension, sex, diabetes duration, smoking and HbA 1 c were entered into a forward stepwise multiple logistic regression analysis (Table 3 ). In addition to glycaemic control and male sex, both parental history of Type II diabetes and hypertension were found to be independently associated with diabetic nephropathy with odds ratios of 2.9 and 2.1, respectively. To quantify the effect of parental hypertension on the odds ratio for parental Type II diabetes, parental hypertension was omitted from the model. In this model, the sex-and HbA 1 c -adjusted odds ratio for parental Type II diabetes was 3.3 (95 % CI: 1.2 to 9.2).
Patients with a family history of Type II diabetes were slightly older (44 ± 1 vs 41 ± 1 years, p = 0.039), had higher WHR (men: 0.95 ± 0.01 vs 0.91 ± 0.01, p = 0.039; women 0.85 ± 0.02 vs 0.82 ± 0.01, p = 0.054), higher systolic blood pressure (154 ± 3 vs 146 ± 2, p = 0.040), a higher prevalence of nephropathy (87 vs 68 %, p = 0.019) and a family history of hypertension (67 vs 46 %, p = 0.019) compared with patients without a family history of Type II diabetes.
Characteristics of parents without a history of diabetes. Data on the 95 parents of patients with nephropa- Data is number (%) thy and 55 parents of patients without nephropathy without a history of diabetes who had an OGTT are in Table 4 . Parents of patients with nephropathy had higher fasting plasma glucose concentrations and were more often treated for hypertension. Fathers of patients with nephropathy had higher WHR and tended to be more glucose intolerant compared with fathers of patients without nephropathy.
Discussion
In our case-control study, we report evidence of an association between a familial history of Type II diabetes and diabetic nephropathy in patients with Type I diabetes. Type I diabetic patients with Type II diabetes in one or both parents had a three-fold risk of diabetic nephropathy compared with patients without parental Type II diabetes. This association was independent of familial hypertension and potential confounding factors. Our observation is based on a higher prevalence of a family history of Type II diabetes in Type I diabetic patients with diabetic nephropathy compared with those without diabetic renal disease. Before any further conclusions can be drawn, any effect of potential confounding factors must be carefully evaluated. The prevalence of diabetes increases steeply with age [29] and a difference in prevalence could be the result of a difference in age between the groups of parents. In line with previous reports [14, 15] , however, survival was poorer among parents of patients with nephropathy. The time at risk of developing diabetes was thus shorter among parents of patients with nephropathy, an observation that further strengthens our finding of an increased prevalence of Type II diabetes in this group. Furthermore, sex-specific effects of a family history of Type II diabetes [20] have been reported. There were more men among patients with nephropathy, probably due to the fact that male sex is a risk factor for nephropathy [1] and no attempt was made to match the patients with and without nephropathy for this variable. Logistic regression analysis showed, however, an association of familial history of Type II diabetes with diabetic nephropathy that was independent of sex.
In Pima Indians, diabetic nephropathy in parents, compared with parental diabetes alone, has been found to be associated with an increased risk for diabetes in the offspring [27] . Another study in the same population suggested an increased prevalence of proteinuria in Type II diabetic patients with maternal Type II diabetes compared with those without [30] . Therefore, in Type II diabetes, a link between familial Type II diabetes and development of diabetic renal complications seems likely. Familial factors have also been extensively studied in Type I diabetes. Studies evaluating parental hypertension [10, 31, 32] and prevalence [14, 33] or mechanisms [34] of parental cardiovascular disease have reported no excess of parental diabetes in Type I diabetic patients with nephropathy. All these studies, however, were rather small and not specifically designed to study the impact of parental diabetes. A Swedish case-control study in young Type I diabetic patients [13] found only a small increase in parental Type II diabetes among patients with micro-or macroalbuminuria, but the results should be interpreted with caution due to the small number of parents with Type II diabetes.
Two recent large-scale case-control studies have reported data on the impact of a family history of diabetes on the development of micro-and macrovascular complications in Type I diabetes. The Pittsburgh Epidemiology of Diabetes Complications Study [35] found an association between a family history of Type II diabetes and coronary heart disease in Type I diabetic patients. In support of our findings, the prevalence of nephropathy was higher by univariate analysis among Type I diabetic patients with familial Type II diabetes compared with those without. An association of parental diabetes with albuminuria in the Type I diabetic offspring was also observed in the EURODIAB Study [36] . The association was strongest in women, with an odds ratio of albuminuria of 1.4 in female patients with a family history of diabetes. It was weaker in men and only borderline significant in the whole study population. In our study, parental Type II diabetes was associated with an almost three-fold risk of nephropathy which exceeds the 95 % confidence interval of the EURODIAB Study. The classification of patients into albuminuric and normoalbuminuric in the EURODIAB Study, however, was based on a single urine collection. Furthermore, the control group had a relatively short duration of diabetes and could therefore have included a proportion of patients at considerable risk of subsequent development of nephropathy. Misclassification of cases and control subjects in a study with a casecontrol design will lead to an underestimation of any associated phenomenon. Therefore, the stronger association between diabetic nephropathy and parental Type II diabetes found by us is most likely a result of the more robust classification used in our study. We have recently confirmed the previously somewhat controversial association of predisposition to hypertension and diabetic nephropathy in Type I diabetes [10±12, 31]. Our finding here of an adjusted odds ratio of 2.1 for nephropathy in patients reporting antihypertensive therapy in one or both parents provide additional evidence for this association. It should be noted that a family history of Type II diabetes was associated with nephropathy independently of a family history of hypertension. Therefore, a family history of Type II diabetes and familial predisposition to hypertension seem to influence the risk of nephropathy by way of different, but so far unexplained, mechanisms.
We can only speculate about the mechanisms linking a family history of Type II diabetes to diabetic nephropathy in Type I diabetes. Type II diabetes is a heterogenous disease that results from defects in both insulin action and production [16] . The definition of parental Type II diabetes used in our study was based on historical data, which makes a more precise subphenotyping impossible, and the parents with Type II diabetes will indeed include subjects with a different aetiology and with a different impact on the offspring with Type I diabetes. The characteristics of the selected group of surviving non-diabetic parents, however, showed an excess of abdominal obesity, higher fasting plasma glucose and more hypertension in parents of patients with diabetic nephropathy, all factors associated with the insulin resistance syndrome. Furthermore, the Type I diabetic patients with diabetic nephropathy had a higher WHR despite similar BMI compared with patients without nephropathy. Since abdominally distributed fat is closely linked to insulin resistance [37] , this indirectly supports the previous observations, that increased albuminuria is associated with insulin resistance in both Type I [22, 23] and Type II diabetes [38] . Also, insulin resistance has been found to be predictive of subsequent development of microalbuminuria [39] , which could indicate a causal relation between insulin resistance and development of diabetic microvascular complications. Insulin resistance could therefore be the common denominator linking a family history of Type II diabetes to the development of diabetic nephropathy in Type I diabetes. On the other hand, Type I diabetic patients with residual beta-cell function are less prone to develop microvascular complications compared with patients with complete loss of beta-cell function [40] . An inherited defect in insulin production, perhaps resulting in a more complete loss of beta-cell function at the time of onset of diabetes, could therefore also increase the risk of diabetic nephropathy in Type I diabetic patients with a family history of Type II diabetes.
What are the implications of our finding of an excess of Type II diabetes in parents of patients with nephropathy? A sedentary family lifestyle could possibly predispose both to parental Type II diabetes and nephropathy in the offspring ± for instance, there are some indications of a protective effect of physical exercise on the development of retinopathy in Type I diabetes [41] . Although common environmental factors may be important in the genesis of both Type II diabetes in parents and diabetic nephropathy in the offspring with Type I diabetes, one must also consider genetic factors in the observed familial clustering of the two diseases. The Trp64Arg mutation of the b 3 -adrenergic-receptor gene, previously associated with earlier onset of Type II diabetes in Pima Indians [42] , abdominal obesity and insulin resistance [43] and an increased tendency to gain weight in Caucasians [44] , has recently been associated with the development of both proliferative retinopathy [45] and diabetic nephropathy [46] in Japanese Type II diabetic patients. Therefore, based on our findings, the b 3 -adrenergic-receptor gene as well as any other gene related to Type II diabetes, insulin resistance, impaired insulin secretion or obesity, need to be tested as candidate genes for diabetic nephropathy also in Type I diabetic patients.
In conclusion, a family history of Type II diabetes is associated with a three-fold risk of diabetic nephropathy in Type I diabetes. Genetic or environmental factors or both related to familial Type II diabetes seem to increase susceptibility to diabetic nephropathy in patients with Type I diabetes.
